Exact Sciences buy Benchmark Co.
Start price
02.01.24
/
50%
€69.19
Target price
02.01.25
€83.05
Performance (%)
-20.39%
End price
03.01.25
€55.08
Summary
This prediction ended on 03.01.25 with a price of €55.08. The price of Exact Sciences has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.39%. Benchmark_Co_ has a follow-up prediction for Exact Sciences where he still thinks Exact Sciences is a Buy. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exact Sciences | 0.000% | 0.000% | 120.832% |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % |
Comments by Benchmark_Co_ for this prediction
In the thread Exact Sciences diskutieren
Exact Sciences Co. (NASDAQ: EXAS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $91.00 price target on the stock.
Ratings data for EXAS provided by MarketBeat
In the thread Trading Exact Sciences
Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten